Condition
    Strong Evidence
    Effectiveness 3/5

    Potassium for Elevated Blood Pressure

    Raising potassium intake lowers systolic blood pressure by roughly 4-5 mmHg in hypertensive adults, with the largest benefit in people eating high-sodium diets.

    Overview

    Raising potassium intake lowers blood pressure. This is one of the better-supported nutrition findings in cardiovascular medicine: a JAMA meta-analysis of randomised trials, a BMJ systematic review commissioned for WHO guidance, and a 2020 dose-response meta-analysis in the Journal of the American Heart Association all converge on a reduction of roughly 3 to 5 mmHg systolic in people with hypertension. The effect is largest in exactly the people who need it: those with established hypertension and those eating a high-sodium diet. In people with normal blood pressure and moderate salt intake, the change is small. And the route matters more here than for almost any other supplement — food potassium is broadly safe, while high-dose potassium salts carry real cardiac risk in the wrong person.

    Verdict

    Likely effective

    Randomised trial meta-analyses show increased potassium intake lowers systolic blood pressure by roughly 3-5 mmHg in hypertensive adults, with the largest effect in high-sodium diets and no benefit in normotensive people.

    How It Works

    Potassium lowers blood pressure mainly by pushing sodium out. Higher potassium intake increases natriuresis at the distal nephron, reduces extracellular fluid volume, and blunts the sodium retention that drives salt-sensitive hypertension. That is why the effect scales with dietary sodium: the more salt in the diet, the more there is for potassium to counteract. There are vascular effects too. Potassium hyperpolarises vascular smooth muscle and stimulates endothelial nitric oxide production, promoting vasodilation, and it modestly suppresses renin-angiotensin-aldosterone activity. Together these explain why the blood pressure change appears within weeks rather than requiring long-term remodelling.

    Pathways involved

    Renal sodium excretion
    Extracellular volume reduction
    Endothelial nitric oxide release
    Vascular smooth muscle hyperpolarisation
    Renin-angiotensin-aldosterone modulation

    Dosing & Protocol

    Trials achieved benefit at total intakes of roughly 3,500 to 4,700 mg per day, which is also the WHO and US adequate intake target. Most adults consume around 2,000 to 2,600 mg, so the gap is about 1,500 to 2,000 mg. Supplemental doses in trials were typically 1,500 to 3,000 mg per day of potassium chloride or citrate in divided doses. Food is the preferred route and the reason is regulatory, not sentimental: over-the-counter potassium supplements in many countries are capped at 99 mg per tablet precisely because larger single doses can cause gastrointestinal ulceration and dangerous rises in serum potassium. Potassium-rich foods deliver the same anion load spread across the day. Higher-dose potassium salts, including salt substitutes, belong under clinical supervision when kidney function or medications are involved.
    ApproachAmountFormNotes
    Daily intake target3,500-4,700 mg totalDiet plus any supplementWHO and US adequate intake range
    Trial supplemental dose1,500-3,000 mg/dayPotassium chloride or citrate, dividedUsed under trial monitoring
    OTC supplement cap99 mg per tabletPotassium gluconate or chlorideRegulatory limit in many countries
    Salt substituteTypically 25-65% potassium chlorideTable useRequires normal kidney function
    Food equivalents~420 mg banana, ~900 mg baked potato, ~840 mg cup of beansWhole foodsSafest route to the target
    1. 1

      Check kidney function first· Before starting

      An eGFR and serum potassium before increasing intake. Chronic kidney disease changes this from helpful to hazardous.

    2. 2

      Review your medication list· Before starting

      ACE inhibitors, ARBs, spironolactone, amiloride, trimethoprim and NSAIDs all raise potassium. Increasing intake on top of these needs supervision.

    3. 3

      Raise food potassium first· Weeks 1-4

      Leafy greens, potatoes with skin, beans, yoghurt, tomatoes, avocado, citrus. Aim to close the gap to roughly 3,500-4,700 mg daily.

    4. 4

      Cut sodium at the same time· Ongoing

      The blood pressure effect is largest when sodium is high, and the two changes together outperform either alone.

    5. 5

      Recheck blood pressure at 4-6 weeks· Week 4-6

      Expect a change of a few mmHg, not a transformation. Home readings averaged over a week are more informative than a single clinic value.

    Evidence

    The 1997 JAMA meta-analysis of randomised trials of oral potassium found reductions of roughly 3.1 mmHg systolic and 2.0 mmHg diastolic, with larger effects in people on high-sodium diets. The 2013 BMJ systematic review, prepared to inform WHO guidance, reported around a 3.5 mmHg systolic fall in hypertensive adults, no significant change in normotensive adults, and no adverse effect on renal function or lipids at these intakes. The 2020 dose-response meta-analysis in the Journal of the American Heart Association refined the picture, showing the greatest benefit in hypertensive people and in those with high sodium intake, with the curve flattening once intake reaches the adequate range. The PURE cohort adds observational support linking higher urinary potassium excretion to lower blood pressure and reduced cardiovascular events, though as a cohort it cannot establish causation.
    Best available evidence
    Three meta-analyses of randomised trials plus a large international cohort
    Typical effect
    3-5 mmHg systolic reduction in hypertensive adults
    Who benefits most
    People with hypertension and high sodium intake
    Who benefits least
    Normotensive adults with moderate sodium intake
    Time to effect
    4-6 weeks
    Certainty of evidence
    Moderate to strong for blood pressure; weaker for hard cardiovascular outcomes from supplements specifically

    Three meta-analyses of randomised controlled trials of potassium intake and blood pressure, including the WHO-commissioned BMJ review and a 2020 dose-response analysis, plus the PURE cohort on urinary potassium excretion and cardiovascular events.

    Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials

    Score: 8/10
    2020
    meta_analysis

    Filippini T, Naska A, Kasdagli MI +8 more

    Blood pressure fell with increasing potassium intake up to about 90 mmol/day, with the strongest effects in hypertensive participants not on medication

    View source

    Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses

    Score: 9/10
    2013
    meta_analysis

    Aburto NJ, Hanson S, Gutierrez H +3 more

    Higher potassium intake reduced systolic blood pressure by about 3.5 mmHg in hypertensive adults and was associated with a 24% lower risk of stroke

    View source

    Urinary sodium and potassium excretion, mortality, and cardiovascular events (PURE)

    Score: 7/10
    2014
    cohort
    n=101945

    O Donnell M, Mente A, Rangarajan S +26 more

    Higher estimated potassium excretion was associated with a lower risk of death and cardiovascular events

    View source

    Effects of oral potassium on blood pressure: meta-analysis of randomized controlled clinical trials

    Score: 8/10
    1997
    meta_analysis
    n=2609

    Whelton PK, He J, Cutler JA +4 more

    Potassium supplementation reduced systolic blood pressure by 3.11 mmHg and diastolic by 1.97 mmHg, with larger effects in those with high sodium intake

    View source

    Safety

    From food, potassium is safe for people with healthy kidneys — the kidney excretes the excess and no upper limit has been set for dietary intake. From supplements and salt substitutes the picture changes. Hyperkalaemia can cause muscle weakness, palpitations and, at severe levels, cardiac arrhythmia and arrest, and it can develop without warning symptoms. The people at risk are identifiable in advance: chronic kidney disease at any stage, adrenal insufficiency, uncontrolled diabetes, and anyone taking ACE inhibitors, angiotensin receptor blockers, potassium-sparing diuretics such as spironolactone or amiloride, trimethoprim, heparin or regular NSAIDs. High-dose oral potassium salts can also cause gastrointestinal ulceration and bleeding, which is why single-tablet doses are capped. Potassium supplementation is an adjunct to antihypertensive treatment, never a replacement for it.

    Do not self-supplement with reduced kidney function

    If you have chronic kidney disease, or take an ACE inhibitor, ARB, spironolactone or amiloride, do not add potassium supplements or potassium-based salt substitutes without a serum potassium check and clinician approval. Hyperkalaemia can be fatal and often gives no warning.

    Interactions & Conflicts

    Interacts withSeverityMechanismAction
    ACE inhibitors and ARBs
    high
    		Reduced aldosterone-driven potassium excretionDo not supplement without monitoring serum potassium
    Potassium-sparing diuretics (spironolactone, amiloride, eplerenone)
    high
    		Direct blockade of renal potassium lossAvoid supplements; caution with salt substitutes
    Chronic kidney disease
    high
    		Impaired renal excretion of a potassium loadIntake set by nephrology, not by general targets
    Trimethoprim and heparin
    moderate
    		Reduced potassium excretion and aldosterone suppressionMonitor potassium during treatment
    NSAIDs
    moderate
    		Reduced renal perfusion and potassium excretionAvoid regular combined use without monitoring
    Digoxin
    moderate
    		Both hypokalaemia and hyperkalaemia alter digoxin toxicity riskKeep potassium stable and monitored
    Thiazide and loop diuretics
    low
    		These lower potassium, so intake may need to riseAdjust on measured levels rather than assumption

    References

    1. Whelton PK et al. Effects of oral potassium on blood pressure: meta-analysis of randomized controlled clinical trials. JAMA. 1997
    2. Aburto NJ et al. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ. 2013
    3. Filippini T et al. Potassium intake and blood pressure: a dose-response meta-analysis of randomized controlled trials. J Am Heart Assoc. 2020

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.